Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Bryson

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
The Biochemical Journal|January 22, 2000
Evidence that the inhibition of cartilage proteoglycan breakdown by mannosamine is not mediated via inhibition of glycosylphosphatidylinositol anchor formationH Bryson, D J Buttle, L D Kozaci, et al.
MMWR. CDC Surveillance Summaries : Morbidity and Mortality Weekly Report. CDC Surveillance Summaries|September 1, 1988
Rabies surveillance, United States, 1987D B Fishbein, J G Dobbins, J H Bryson, et al.
Archives of Biochemistry and Biophysics|July 2, 1998
A serine proteinase inactivator inhibits chondrocyte-mediated cartilage proteoglycan breakdown occurring in response to proinflammatory cytokinesH Bryson, R A Bunning, R Feltell, et al.
MMWR. CDC Surveillance Summaries : Morbidity and Mortality Weekly Report. CDC Surveillance Summaries|August 1, 1989
Rabies surveillance, United States, 1988T R Eng, T A Hamaker, J G Dobbins, et al.
Acta Psychiatrica Scandinavica. Supplementum|May 7, 2004
Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) projectJ Alonso, M C Angermeyer, S Bernert, et al.
Acta Psychiatrica Scandinavica. Supplementum|May 7, 2004
Psychotropic drug utilization in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) projectJ Alonso, M C Angermeyer, S Bernert, et al.
Acta Psychiatrica Scandinavica. Supplementum|May 7, 2004
Sampling and methods of the European Study of the Epidemiology of Mental Disorders (ESEMeD) projectJ Alonso, M C Angermeyer, S Bernert, et al.
Acta Psychiatrica Scandinavica. Supplementum|May 7, 2004
12-Month comorbidity patterns and associated factors in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) projectJ Alonso, M C Angermeyer, S Bernert, et al.
Acta Psychiatrica Scandinavica. Supplementum|May 7, 2004
Disability and quality of life impact of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) projectJ Alonso, M C Angermeyer, S Bernert, et al.
Acta Psychiatrica Scandinavica. Supplementum|May 7, 2004
Use of mental health services in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) projectJ Alonso, M C Angermeyer, S Bernert, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
The Biochemical Journal|January 22, 2000
Evidence that the inhibition of cartilage proteoglycan breakdown by mannosamine is not mediated via inhibition of glycosylphosphatidylinositol anchor formationH Bryson, D J Buttle, L D Kozaci, et al.
MMWR. CDC Surveillance Summaries : Morbidity and Mortality Weekly Report. CDC Surveillance Summaries|September 1, 1988
Rabies surveillance, United States, 1987D B Fishbein, J G Dobbins, J H Bryson, et al.
Archives of Biochemistry and Biophysics|July 2, 1998
A serine proteinase inactivator inhibits chondrocyte-mediated cartilage proteoglycan breakdown occurring in response to proinflammatory cytokinesH Bryson, R A Bunning, R Feltell, et al.
MMWR. CDC Surveillance Summaries : Morbidity and Mortality Weekly Report. CDC Surveillance Summaries|August 1, 1989
Rabies surveillance, United States, 1988T R Eng, T A Hamaker, J G Dobbins, et al.
Acta Psychiatrica Scandinavica. Supplementum|May 7, 2004
Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) projectJ Alonso, M C Angermeyer, S Bernert, et al.
Acta Psychiatrica Scandinavica. Supplementum|May 7, 2004
Psychotropic drug utilization in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) projectJ Alonso, M C Angermeyer, S Bernert, et al.
Acta Psychiatrica Scandinavica. Supplementum|May 7, 2004
Sampling and methods of the European Study of the Epidemiology of Mental Disorders (ESEMeD) projectJ Alonso, M C Angermeyer, S Bernert, et al.
Acta Psychiatrica Scandinavica. Supplementum|May 7, 2004
12-Month comorbidity patterns and associated factors in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) projectJ Alonso, M C Angermeyer, S Bernert, et al.
Acta Psychiatrica Scandinavica. Supplementum|May 7, 2004
Disability and quality of life impact of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) projectJ Alonso, M C Angermeyer, S Bernert, et al.
Acta Psychiatrica Scandinavica. Supplementum|May 7, 2004
Use of mental health services in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) projectJ Alonso, M C Angermeyer, S Bernert, et al.
Pageof 2